hVEGF-IN-1 ol-7-O-β-D-glucopyranoside Xanthohumol (5-50 nM) reduces the

Xanthohumol (5-50 nM) reduces the frequency of spontaneously occurring Ca2+ sparks and Ca2+ waves in control myocytes and in cells subjected to Ca2+ overload caused by: (1) exposure to low K+ solutions

Dorweiler I

Formula: C18H14F4N2O4S

3-dihydro-1H-inden-4-yl)oxy]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide

3)4)55-41(58)15-18-63-20-19-62-16-7-6-8-17-64-40-23-34-37(24-39(40)61-5)51-27-52-44(34)54-32-13-14-36(49)35(48)21-32/h9-14

hVEGF-IN-1 ol-7-O-β-D-glucopyranoside Xanthohumol (5-50 nM) reduces thehVEGF IN 1, a quinazoline derivative, could specifically bind to the G rich sequence in the internal ribosome entry site A (IRES A) and destabilize the G quadruplex structure. hVEGF IN 1 binds to the IRES A (WT) with a Kd of 0. 928 M in SPR experiments. hVEGF IN 1 could hinder tumor cells migration and repress tumor growth by decreasing VEGF A protein expression. Product information CAS Number: 1637443 98 1 Molecular Weight: 581. 75 Formula: